EICHOR
● Recruiting
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Condition: Diabetes Mellitus, Type 1 · Sponsor: Eli Lilly and Company
About this study
The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk to develop T1D. Participation in the study will last up to approximately 5 years.
This description comes directly from the study's public registry record.
Talk to the study team
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
Locations (110)
| Tallahassee Memorial HealthCare | Tallahassee, Florida, United States | Not Yet Recruiting |
| University of South Florida | Tampa, Florida, United States | Suspended |
| University of Iowa | Iowa City, Iowa, United States | Recruiting |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines, Iowa, United States | Recruiting |
| Novak Center for Children's Health | Louisville, Kentucky, United States | Not Yet Recruiting |
| Children's Hospital of Philadelphia (CHOP) | Philadelphia, Pennsylvania, United States | Not Yet Recruiting |
| University of Virginia | Charlottesville, Virginia, United States | Recruiting |
| Women's and Children's Hospital | Adelaide, Australia | Recruiting |
| Box Hill Hospital | Box Hill, Australia | Recruiting |
| Royal Brisbane and Women's Hospital | Brisbane, Australia | Recruiting |
| Centre for Children's Health Research | Brisbane, Australia | Not Yet Recruiting |
| Royal Children's Hospital | Melbourne, Australia | Not Yet Recruiting |
+ 98 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.